|
Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Infectious Diseases
|
NIAID
|
1R03AI067663-01
|
|
THE POLYMORPHISM AND BIOLOGY OF LEISHMANIA BRAZILIENSIS INFECTION
|
SCHRIEFER, ALBERT
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$54,000
|
Infectious Diseases
|
NIAID
|
1R03AI066253-01A1
|
|
DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASIS
|
GOLLOB, KENNETH
|
UNIVERSIDADE FEDERAL DE MINAS GERAIS
|
BRAZIL
|
$54,000
|
Infectious Diseases
|
NIAID
|
1R03AI071057-01
|
|
Spatial clustering pre and post-treatment for schistosomiasis and geohelminths
|
GAZZINELLI, ANDREA
|
UNIVERSIDADE FEDERAL DE MINAS GERAIS
|
BRAZIL
|
$75,600
|
Infectious Diseases
|
NIAID
|
1R01AI064872-01A2
|
|
A Thermostable Measles Vaccine
|
GRIFFITHS, JEFFREY
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$577,563
|
Infectious Diseases
|
NIMH
|
5R01MH072556-03
|
|
The STIRR Intervention for Dually Diagnosed Clients
|
ROSENBERG, STANLEY
|
DARTMOUTH COLLEGE
|
NH
|
$553,218
|
Infectious Diseases
|
NIAID
|
1K22AI068489-01A2
|
|
CD40L and GITRL adjuvants for adenoviral vaccines against HIV
|
STONE, GEOFFREY
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$162,000
|
Infectious Diseases
|
NIAID
|
1R43AI073266-01
|
|
Printed Disposable Sensor for Quantitative HIV RNA Measurement of Viral Load
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
NC
|
$141,240
|
Infectious Diseases
|
NIDA
|
1K23DA020383-01A1
|
|
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users
|
TAYLOR, LYNN
|
MIRIAM HOSPITAL
|
RI
|
$179,212
|
Infectious Diseases
|
NHLBI
|
1K23HL084191-01A1
|
|
CD80 and CD86 mediated innate immune response in sepsis
|
NOLAN, ANNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$159,138
|
Infectious Diseases
|
NIGMS
|
5R01GM063879-06
|
|
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts
|
DANIELL, HENRY
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$281,384
|
Infectious Diseases
|
NHLBI
|
4R37HL071544-06
|
|
Mechanism of Staphylocoagulase-activated Blood Clotting
|
BOCK, PAUL
|
VANDERBILT UNIVERSITY
|
TN
|
$345,375
|
Infectious Diseases
|
NIAID
|
1K22AI070317-01A1
|
|
Essential role of transcription factor Foxp1 in B cell development and function
|
HU, HUI
|
WISTAR INSTITUTE
|
PA
|
$162,000
|
Infectious Diseases
|
NIGMS
|
4R37GM035690-23
|
|
Genetic Aspects of DNA Methylation
|
SELKER, ERIC
|
UNIVERSITY OF OREGON
|
OR
|
$550,917
|
Infectious Diseases
|
NIAID
|
1K22AI065425-01A2
|
|
Eicosanoid Production By Infected Lung Epithelial Cells
|
HURLEY, BRYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$161,304
|
Infectious Diseases
|
NIAID
|
1K22AI070647-01A1
|
|
Ccr4 in the maintenance of thermotolerance and pathogenicity of C. neoformans
|
PANEPINTO, JOHN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$157,443
|
Infectious Diseases
|
NIAID
|
4R37AI016935-24
|
|
Iron transport in Shigella and pathogenic E.coli
|
PAYNE, SHELLEY
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$371,500
|
Infectious Diseases
|
NIAID
|
4R37AI040357-13
|
|
Development of VSV/HIV Recombinants as HIV Vaccines
|
ROSE, JOHN
|
YALE UNIVERSITY
|
CT
|
$330,500
|
Infectious Diseases
|
NIDA
|
5R01DA016188-06
|
|
Male IDUs in Viet Nam: Ethno-Epidemiology of HIV Risk
|
CLATTS, MICHAEL
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$542,951
|
Infectious Diseases
|
NCI
|
4R37CA017542-33
|
|
Genetics of RNA Tumor Viruses
|
MARTIN, G
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$508,803
|
Infectious Diseases
|
NIEHS
|
5F30ES012550-05
|
|
Air Pollution & Respiratory Disease Traineeship
|
HARRIS, AARON
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$51,214
|
Infectious Diseases
|
NIAID
|
5U01AI066327-04
|
|
Rationally designed Rift Valley Fever Virus Vaccine
|
FLICK, RAMON
|
BIOPROTECTION SYSTEMS CORPORATION
|
IA
|
$462,742
|
Infectious Diseases
|
NIGMS
|
5R01GM072778-03
|
|
A Prion Reveals Complex Traits and Phenotypic Diversity
|
TRUE-KROB, HEATHER
|
WASHINGTON UNIVERSITY
|
MO
|
$291,339
|
Infectious Diseases
|
NIDDK
|
5F32DK074348-02
|
|
Hepatoxicity in an African HIV Treatment Cohort
|
HOFFMANN, CHRISTOPHER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$53,992
|
Infectious Diseases
|
NIAID
|
4R37AI033493-15
|
|
Mechanisms of Gonococcal Pilin Antigenic & Phase Variation
|
SEIFERT, H.
|
NORTHWESTERN UNIVERSITY
|
IL
|
$377,500
|
Infectious Diseases
|
NIAID
|
4R37AI034867-15
|
|
Lyosome Mediated Cell Invasion by Trypanosoma Cruzi
|
ANDREWS, NORMA
|
YALE UNIVERSITY
|
CT
|
$482,934
|
Infectious Diseases
|
NIAID
|
4R37AI034266-13
|
|
Infant Immunoprophylaxis against a Primate Lentivirus
|
RUPRECHT, RUTH
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$820,779
|
Infectious Diseases
|
NIAID
|
4R37AI036040-20
|
|
Structural Studies on Rotaviruses
|
PRASAD, BIDADI
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$493,819
|
Infectious Diseases
|
NHLBI
|
5K08HL081229-03
|
|
Role of IRAK-M in sepsis-induced immunosuppression
|
DENG, JANE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$121,770
|
Infectious Diseases
|
NIMH
|
5R34MH075628-03
|
|
Preventing HIV & Drug Use Among Juvenile Offenders
|
DONENBERG, GERI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$228,311
|
Infectious Diseases
|
NIAID
|
2P50AI030639-16
|
0013
|
The role of Leishmania braziliensis strain polymorphism on disease outcome and ..
|
SCHRIEFER, ALBERT
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$195,364
|
Infectious Diseases
|
NIAID
|
2P50AI030639-16
|
0014
|
Protective and Pathogenic Immune Responses in Tegumentary Leishmania
|
CARVALHO, EDGAR
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$197,657
|
Infectious Diseases
|
NIAID
|
2P50AI030639-16
|
0015
|
Genetic Determinants of Leishmaniasis
|
JERONIMO, SELMA
|
FEDERAL UNIVERSITY OF BAHIA
|
BRAZIL
|
$188,710
|
Infectious Diseases
|
NIDA
|
1R01DA021550-01A2
|
|
HCV Transmission among Young IDUs in NYC
|
EDLIN, BRIAN
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$834,452
|
Infectious Diseases
|
FIC
|
1D43TW007391-01A2
|
|
Tsetse Transmitted African Trypanosomiasis
|
AKSOY, SERAP
|
YALE UNIVERSITY
|
CT
|
$141,717
|
Infectious Diseases
|
FIC
|
1R03TW007757-01A1
|
|
Molecular determinants of P. falciparum resistance to ACTs in Nigeria.
|
HAPPI, CHRISTIAN
|
UNIVERSITY OF IBADAN
|
NIGERI
|
$27,918
|
Infectious Diseases
|
NIAID
|
1K22AI074662-01
|
|
Influenza Viral RNA Synthesis and Processing
|
NEWCOMB, LAURA
|
CALIFORNIA STATE UNIV SAN BERNARDINO
|
CA
|
$160,000
|
Infectious Diseases
|
NIAID
|
1K22AI074908-01
|
|
Role of endosomal cysteine protease in Ebola and Marburg virus entry
|
CHANDRAN, KARTIK
|
YESHIVA UNIVERSITY
|
NY
|
$160,440
|
Infectious Diseases
|
NIDCD
|
5R01DC006452-03
|
|
Effect of the Middle Ear Inflammation On the Inner Ear
|
JUHN, STEVEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$304,466
|
Infectious Diseases
|
NIDCD
|
5R03DC007511-03
|
|
In Vivo Virulence Gene Expression in Acute Otitis Media
|
LI-KOROTKY, HA-SHENG
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$69,669
|
Infectious Diseases
|
NIAAA
|
5F31AA016705-02
|
|
Contextualizing Young Women's Experiences of Alcohol and Sexual Risk
|
WELLS, BROOKE
|
CUNY GRADUATE SCH AND UNIV CTR
|
NY
|
$16,055
|
Infectious Diseases
|
NINR
|
5F31NR008964-04
|
|
Partner-type Influence on Condom Use in Adolescent Girls
|
NELSON, LARON
|
UNIVERSITY OF ROCHESTER
|
NY
|
$14,584
|
Infectious Diseases
|
NIAID
|
2R01AI053067-06
|
|
Quorum sensing regulation of EHEC virulence genes
|
SPERANDIO, VANESSA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$451,461
|
Infectious Diseases
|
NCCAM
|
1R21AT003400-01A2
|
|
The Use of VSL#3 in Irritable Bowel Syndrome in Children
|
MICHAIL, SONIA
|
WRIGHT STATE UNIVERSITY
|
OH
|
$189,000
|
Infectious Diseases
|
NIDCD
|
5R01DC007464-03
|
|
NTHi Type IV pili: expression and vaccine potential
|
MUNSON, ROBERT
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$423,695
|
Infectious Diseases
|
NIDCD
|
5R01DC000263-21
|
|
Cellular and Molecular Biology of Cholesteatoma
|
CHOLE, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$333,587
|
Infectious Diseases
|
NIAID
|
5R01AI057552-04
|
|
International Herpes Vaccine Project
|
KNIPE, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$394,157
|
Infectious Diseases
|
NIAID
|
5R01AI072296-02
|
|
The role of IL-4 and IL-4Ralpha in the multi-step process of Th2 development
|
MOHRS, MARKUS
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$392,891
|
Infectious Diseases
|
NIAID
|
5R01AI054359-05
|
|
Immune Induction to Genital Herpes Simplex Virus 2
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$266,144
|
Infectious Diseases
|
NIGMS
|
5R01GM060620-09
|
|
Mechanism of RNA Helicase Activity by DExH/D Proteins
|
PYLE, ANNA
|
YALE UNIVERSITY
|
CT
|
$239,995
|
Infectious Diseases
|
NIAID
|
5R01AI055358-05
|
|
Regulation of Macrophage Cell Death by Toxoplasma gondii
|
ORLOFSKY, AMOS
|
YESHIVA UNIVERSITY
|
NY
|
$388,343
|
Infectious Diseases
|
NCI
|
4R37CA042245-23
|
|
Regulation of replication and latency EBV EBNAs
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$367,373
|
Infectious Diseases
|
NIGMS
|
5R01GM026796-25
|
|
Mechanism of Protein Synthesis Initiation
|
MERRICK, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$364,543
|
Infectious Diseases
|
NIGMS
|
5R01GM031186-25
|
|
Enzymatic Mechanisms of Sulfur Nucleoside Metabolism
|
MARKHAM, GEORGE
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$381,378
|
Infectious Diseases
|
NIGMS
|
5R01GM059334-09
|
|
MICROBIAL METABOLISM OF REDUCED PHOSPHORUS COMPOUNDS
|
METCALF, WILLIAM
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$243,864
|
Infectious Diseases
|
NIGMS
|
5R01GM059694-08
|
|
Bacterial Membrane Proteins in Gram-Negative Sepsis
|
WARREN, H
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$352,493
|
Infectious Diseases
|
NIAID
|
5R01AI064616-03
|
|
The Role of Toxoplasma Rhoptries in Host Cell Infection
|
BRADLEY, PETER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$323,656
|
Infectious Diseases
|
NIAID
|
5R01AI052289-05
|
|
Signal Transduction in Enterococci
|
PEREGO, MARTA
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$396,601
|
Infectious Diseases
|
NIAID
|
5R01AI046148-08
|
|
Identification of Mulit-Drug Resistant HIV-1 Isolates
|
SHAFER, ROBERT
|
STANFORD UNIVERSITY
|
CA
|
$334,861
|
Infectious Diseases
|
NIAID
|
5R01AI033537-15
|
|
Virulence Gene Expression by Bacillus anthracis
|
KOEHLER, THERESA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$239,055
|
Infectious Diseases
|
NIAID
|
5R01AI059327-05
|
|
Synthesis and Mechanistic Studies of Peptide Antibiotics
|
VANNIEUWENHZE, MICHAEL
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$304,603
|
Infectious Diseases
|
NIAID
|
5R01AI059415-04
|
|
Endotoxin Exposure Alters-Anti-Tetanus IgE in Infants
|
OWNBY, DENNIS
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$348,515
|
Infectious Diseases
|
NIAID
|
5R01AI042135-11
|
|
TNF Mediated Immune Defense Against Listeria Infection
|
PAMER, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$430,201
|
Infectious Diseases
|
NIAID
|
5R01AI040588-09
|
|
ROLE OF B.FRAGILIS OXYGEN STRESS RESPONSE IN INFECTION
|
SMITH, CHARLES
|
EAST CAROLINA UNIVERSITY
|
NC
|
$265,097
|
Infectious Diseases
|
NIGMS
|
5R01GM035072-23
|
|
Gene Functions and Molecular Genetics of RNA Viruses
|
AHLQUIST, PAUL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$408,508
|
Infectious Diseases
|
NCI
|
5R01CA040489-23
|
|
Pathogenesis of Hepatitis B Virus in Transgenic Mice
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$792,726
|
Infectious Diseases
|
NIMH
|
5K05MH076273-03
|
|
Treatment of Tourette's Syndrome & Obsessive-Compulsive Disorder
|
LECKMAN, JAMES
|
YALE UNIVERSITY
|
CT
|
$128,304
|
Infectious Diseases
|
NIAID
|
5R01AI047365-09
|
|
Structure and Function of the Hepatitis C Virus Genome
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$362,764
|
Infectious Diseases
|
NIAID
|
5R01AI063402-04
|
|
IDO dependent T cell suppression
|
MELLOR, ANDREW
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$266,027
|
Infectious Diseases
|
NIAID
|
5R01AI062755-04
|
|
Sexually Transmitted Infections & Antimicrobial Peptides
|
SHAFER, WILLIAM
|
EMORY UNIVERSITY
|
GA
|
$318,814
|
Infectious Diseases
|
NIAID
|
5R01AI058057-05
|
|
Function of the gammaHV68 M2 Antigen
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
GA
|
$353,697
|
Infectious Diseases
|
NIAID
|
5R01AI055268-05
|
|
IMPDH as a Drug Target in Cryptosporidium
|
STRIEPEN, BORIS
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$298,836
|
Infectious Diseases
|
NIGMS
|
5R01GM031847-25
|
|
Hydrogen exchange, proteins, folding, and misfolding
|
ENGLANDER, S.
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$369,812
|
Infectious Diseases
|
NIAID
|
5R01AI064738-03
|
|
RNAi as an Intercellular Antiviral Defense Mechanism
|
ANDINO, RAUL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$319,446
|
Infectious Diseases
|
NIAID
|
2R01AI020001-25
|
|
Pathogenesis of Liver Disease in Hepatitis
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$685,357
|
Infectious Diseases
|
NIAID
|
5R01AI036973-14
|
|
Gene Regulation and Virulence in TB and MAC
|
BISHAI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$381,367
|
Infectious Diseases
|
NIGMS
|
5R01GM053209-14
|
|
Programmed Cell Death: Role in Septic Immune Dysfunction
|
AYALA, ALFRED
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$259,170
|
Infectious Diseases
|
NIAID
|
5R01AI064671-03
|
|
Biology of the Apicomplexan Plastid
|
STRIEPEN, BORIS
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$280,431
|
Infectious Diseases
|
NIAID
|
5R01AI059614-04
|
|
Production of Antibodies in Algae for Biodefense
|
MAYFIELD, STEPHEN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$396,601
|
Infectious Diseases
|
NIAID
|
5R01AI063080-03
|
|
Role of Pertussis Toxin in Bordetella pertussis infection
|
CARBONETTI, NICHOLAS
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$353,635
|
Infectious Diseases
|
NIAID
|
5R01AI042023-10
|
|
Control of Paramyxovirus RNA Synthesis
|
PARKS, GRIFFITH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$233,588
|
Infectious Diseases
|
NIAID
|
5R01AI068056-03
|
|
Generation and maintenance of influenza-specific plasma and memory B cells
|
LUND, FRANCES
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$375,067
|
Infectious Diseases
|
NIAID
|
5R01AI064789-03
|
|
Nitric oxide and mitochondrial biogenesis in sepsis
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$260,046
|
Infectious Diseases
|
NIAID
|
1R01AI068932-01A2
|
|
Evolutionary genetics of tsetse and its symbionts
|
AKSOY, SERAP
|
YALE UNIVERSITY
|
CT
|
$782,008
|
Infectious Diseases
|
NIAID
|
5R01AI054425-04
|
|
Bacterial host mimicry and chronic airway infection
|
SWORDS, WILLIAM
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$266,957
|
Infectious Diseases
|
NIAID
|
5R01AI057460-05
|
|
Group 1 CD1 in Infectious Disease and T Cell Development
|
WANG, CHYUNG-RU
|
UNIVERSITY OF CHICAGO
|
IL
|
$46,390
|
Infectious Diseases
|
NIAID
|
5R01AI060836-03
|
|
Herpes Simplex Virus Capsid Assembly and DNA Packaging
|
HOMA, FREDERICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$318,271
|
Infectious Diseases
|
NIAID
|
5R01AI044821-09
|
|
Repression and Activation of Persisting HSV Genomes
|
DELUCA, NEAL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$304,301
|
Infectious Diseases
|
NCI
|
5R01CA106258-05
|
|
Mechanisms of human T-cell immortalization by HTLV-I Tax
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$219,529
|
Infectious Diseases
|
NIAID
|
5R01AI049301-07
|
|
How do you build a parasite?
|
MURRAY, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$361,918
|
Infectious Diseases
|
NIAID
|
5R01AI049361-05
|
|
The role of Notch signaling in T cell function
|
OSBORNE, BARBARA
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$321,684
|
Infectious Diseases
|
NIDCD
|
5R01DC004173-08
|
|
The Role of Biofilms in the Pathogenesis of Otorrhea
|
EHRLICH, GARTH
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
PA
|
$818,770
|
Infectious Diseases
|
NIAID
|
5R01AI045086-11
|
|
CYTOADHERENCE IN MATERNAL MALARIA
|
GOWDA, CHANNE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$271,442
|
Infectious Diseases
|
NIAID
|
5R01AI061580-03
|
|
Regulation of RNA editing in Trypansoma brucei
|
READ, LAURIE
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$294,315
|
Infectious Diseases
|
NIAID
|
5R01AI063230-04
|
|
Functional Analysis of Cu/Zn Superoxide Dismutase
|
SLAUCH, JAMES
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$338,953
|
Infectious Diseases
|
NIAID
|
5R01AI026585-19
|
|
Gene Expression of Negative strand RNA Viruses
|
BANERJEE, AMIYA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$416,394
|
Infectious Diseases
|
NIAID
|
5R01AI042797-11
|
|
Targeting of Yop Proteins by Yersinia enterocolitica
|
SCHNEEWIND, OLAF
|
UNIVERSITY OF CHICAGO
|
IL
|
$306,506
|
Infectious Diseases
|
NIGMS
|
5R01GM066786-05
|
|
Cell-Cell Communicaton in Bacterial Quorum Sensing
|
LEVCHENKO, ANDRE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$297,308
|
Infectious Diseases
|
NIMH
|
5R01MH065849-05
|
|
Intervention for Female Workers in Mexico
|
PATTERSON, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$746,976
|
Infectious Diseases
|
NIAID
|
5R01AI062921-04
|
|
Role of Macrophage Arginase in Anti-Bacterial Immunity
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$244,169
|
Infectious Diseases
|
NIMH
|
5R01MH067990-05
|
|
Fronto-Striatal Dysfunction in IFNa-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$261,130
|
Infectious Diseases
|
NIAID
|
5R01AI057468-04
|
|
Role of Interferon-lambda in Antiviral Response
|
KOTENKO, SERGEI
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$361,601
|
Infectious Diseases
|
NIMH
|
5K05MH069124-05
|
|
Pathology and Treatment of Cytokine-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$116,932
|
Infectious Diseases
|
NIAID
|
5R01AI059406-04
|
|
SHIP-2 influence on macrophage Fc receptor function
|
TRIDANDAPANI, SUSHEELA
|
OHIO STATE UNIVERSITY
|
OH
|
$278,119
|
Infectious Diseases
|
NIAID
|
5R01AI060761-03
|
|
Arabidopsis basal innate immunity to bacterial infection
|
HE, SHENG
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$347,413
|
Infectious Diseases
|
NCI
|
5R01CA081310-07
|
|
Effect of Oxidant Load on HPV Persistence and CIN (SIL)
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$459,600
|
Infectious Diseases
|
NIAID
|
5R01AI067731-03
|
|
Antigen-specific CD8+ T cells and protective immunity to tuberculosis
|
BEHAR, SAMUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$393,521
|
Infectious Diseases
|
NIAID
|
5R01AI061381-03
|
|
Pilus Assembly in Gram-Positive Bacteria
|
TON-THAT, HUNG
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$317,200
|
Infectious Diseases
|
NIAID
|
5R01AI043524-09
|
|
Bacteria, Signaling & Leukocyte Transcription Activation
|
PAN, ZHIXING
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$282,526
|
Infectious Diseases
|
NIGMS
|
5R01GM052216-12
|
|
Arsenate resistance in prokaryotes and eukaryotes
|
ROSEN, BARRY
|
WAYNE STATE UNIVERSITY
|
MI
|
$227,147
|
Infectious Diseases
|
NIMH
|
5R01MH067734-06
|
|
Genetics of Simian Immunodeficiency Virus Encephalopathy
|
GONZALEZ-SCARANO, FRANCISCO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$93,588
|
Infectious Diseases
|
NIAID
|
5R01AI053615-05
|
|
Mechanism for Activation of the Antiviral Kinase PKR
|
COLE, JAMES
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$240,913
|
Infectious Diseases
|
NIAID
|
5R01AI064017-05
|
|
S-Adenosylmethionine and Pneumocystis treatment
|
MERALI, SALIM
|
TEMPLE UNIVERSITY
|
PA
|
$342,524
|
Infectious Diseases
|
NIAID
|
5R01AI064844-03
|
|
Role of Hepatitis B virus X protein in HBV replication.
|
BOUCHARD, MICHAEL
|
DREXEL UNIVERSITY
|
PA
|
$315,019
|
Infectious Diseases
|
NIAID
|
5R01AI032178-15
|
|
Plasmid-Mediated Virulence in Salmonella
|
GUINEY, DONALD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$353,462
|
Infectious Diseases
|
NIAID
|
5R01AI063523-04
|
|
Biosynthesis and Function of Base J
|
SABATINI, ROBERT
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$316,128
|
Infectious Diseases
|
NIGMS
|
5R01GM036387-19
|
|
Regulation of Caspase-1 Signaling and Inflammation by the P2X7 ATP Receptor
|
DUBYAK, GEORGE
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$355,350
|
Infectious Diseases
|
NIAID
|
5R01AI042792-09
|
|
Tick-Mammal Interface of Human Granulocytic Anaplasmosis
|
MUNDERLOH, ULRIKE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$513,217
|
Infectious Diseases
|
NIAID
|
5R01AI046428-09
|
|
Gene Expression in Mycobacterium Tuberculosis
|
CLARK-CURTISS, JOSEPHINE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$312,886
|
Infectious Diseases
|
NIAID
|
5R01AI059650-05
|
|
Host response to Chlamydia genital infection in the male
|
RANK, ROGER
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$332,534
|
Infectious Diseases
|
NIAID
|
5R01AI064848-03
|
|
Tandemly Repetitive Proteins in Mycoplasmas
|
DYBVIG, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$311,841
|
Infectious Diseases
|
NIAID
|
1R43AI075645-01
|
|
Pseudo Target Amplification Diagnostics
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
NC
|
$141,240
|
Infectious Diseases
|
NIAID
|
5R01AI039614-12
|
|
Tracking CD4+ Memory T Cells in Vivo
|
JENKINS, MARC
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$349,557
|
Infectious Diseases
|
NIAID
|
5R01AI045990-08
|
|
Reovirus protein s3:Structural and regulatory functions
|
SCHIFF, LESLIE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$304,679
|
Infectious Diseases
|
NIAID
|
5R01AI053835-05
|
|
Regulation of mRNA Turnover in Trypanosomes
|
BELLOFATTO, VIVIAN
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$253,121
|
Infectious Diseases
|
NIAID
|
5R01AI059533-04
|
|
T cell immune response to group A streptococci in NALT
|
CLEARY, PAUL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$273,089
|
Infectious Diseases
|
NIDCD
|
5K23DC008539-02
|
|
Viral determinants of Cytomegalovirus related hearing loss
|
ROSS, SHANNON
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$143,123
|
Infectious Diseases
|
NIAID
|
5R01AI035726-13
|
|
Class II MHC Transport and Function
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$367,923
|
Infectious Diseases
|
NIDDK
|
5R01DK047343-14
|
|
Role of Substance P in Intestinal Inflammation
|
POTHOULAKIS, CHARALABOS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$336,285
|
Infectious Diseases
|
NIAID
|
5R01AI042154-10
|
|
Structure and Function of Hexapeptide Acyltransferases
|
RODERICK, STEVEN
|
YESHIVA UNIVERSITY
|
NY
|
$270,213
|
Infectious Diseases
|
NIAID
|
5R01AI031088-14
|
|
Iron acqisition in Bordetella pertussis
|
ARMSTRONG, SANDRA
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$274,844
|
Infectious Diseases
|
NIAID
|
5R01AI058613-40
|
|
STRUCTURE AND SYNTHESIS OF DNA
|
ENGLUND, PAUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$740,636
|
Infectious Diseases
|
NIGMS
|
5R01GM050441-14
|
|
Post-Traumatic Sepsis: Regulation of LPS Binding Protein
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$264,958
|
Infectious Diseases
|
NIAID
|
5R01AI043356-10
|
|
sar-mediated regulation in Staphylococcus aureus
|
SMELTZER, MARK
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$264,167
|
Infectious Diseases
|
NIAID
|
5R01AI035817-14
|
|
Mechanism and function of unipolarity of Shigella IcsA
|
GOLDBERG, MARCIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$406,520
|
Infectious Diseases
|
NIAID
|
5R01AI057591-04
|
|
Alteration of innate immunity by HCV core
|
HAHN, YOUNG
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$282,356
|
Infectious Diseases
|
NIDDK
|
5K01DK073480-03
|
|
Glycolipid Trafficking of Cholera Toxin by Lipid Rafts
|
SASLOWSKY, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$130,140
|
Infectious Diseases
|
NIAID
|
5R01AI045053-08
|
|
Recognition of bacterial antigens by NKT cells
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$361,588
|
Infectious Diseases
|
NIAID
|
5R01AI058054-05
|
|
Molecular Evolution of Eukaryotes: a protistan emphasis
|
SOGIN, MITCHELL
|
MARINE BIOLOGICAL LABORATORY
|
MA
|
$532,619
|
Infectious Diseases
|
NIAID
|
5R01AI035370-14
|
|
Human Antibodies to Cryptococcus Neoformans
|
PIROFSKI, LIISE-ANNE
|
YESHIVA UNIVERSITY
|
NY
|
$386,018
|
Infectious Diseases
|
NIAID
|
5R01AI056070-04
|
|
Antibody Protection in Histoplamosis
|
NOSANCHUK, JOSHUA
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
Infectious Diseases
|
NIAID
|
5R01AI064831-03
|
|
Malaria: Immunity and Diversity in Low Transmission
|
BRANCH, ORALEE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$389,480
|
Infectious Diseases
|
NIGMS
|
5R01GM049076-13
|
|
Chemical Models of Protein beta-Sheet Interactions
|
NOWICK, JAMES
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$252,598
|
Infectious Diseases
|
NHLBI
|
5K08HL078727-04
|
|
Modulation of Lung Innate Immunity by Prostaglandin E2
|
ARONOFF, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$132,300
|
Infectious Diseases
|
NHLBI
|
5R01HL079142-04
|
|
IL-23 / Il-17 and Lung Host Defense
|
KOLLS, JAY
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$379,418
|
Infectious Diseases
|
NIGMS
|
4R37GM027750-29
|
|
Structure/Function of Microbial Sensory Rhodopsins
|
SPUDICH, JOHN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$681,807
|
Infectious Diseases
|
NIAID
|
1R01AI075459-01
|
|
Signaling in Plasmodium falciparum: Role of PfPLC and PfPKB
|
SHARMA, PUSHKAR
|
NATIONAL INSTITUTE OF IMMUNOLOGY
|
INDIA
|
$56,160
|
Infectious Diseases
|
NIAID
|
1R01AI075452-01
|
|
Transmission dynamics of cryptosporidial infections in India
|
KANG, GAGANDEEP
|
CHRISTIAN MEDICAL COLLEGE
|
INDIA
|
$81,000
|
Infectious Diseases
|
NIAID
|
1R01AI075416-01
|
|
Population structure and transmission dynamics of Plasmodium vivax
|
FERREIRA, MARCELO
|
UNIVERSITY OF SAO PAULO
|
BRAZIL
|
$79,200
|
Infectious Diseases
|
NIGMS
|
5R01GM037049-22
|
|
Mechanism of Yeast Transcriptional Regulators
|
JOHNSON, ALEXANDER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$358,672
|
Infectious Diseases
|
NIAID
|
5R01AI067952-03
|
|
AAV and the DNA Damage Machinery
|
WEITZMAN, MATTHEW
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
CA
|
$406,787
|
Infectious Diseases
|
NIAID
|
5R01AI049342-07
|
|
A Non-Human Primate Model for Cytomegalovirus Vaccines
|
BARRY, PETER
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$405,662
|
Infectious Diseases
|
NIAID
|
5R01AI057870-05
|
|
CHARACTERIZATION OF ANTHRAX TOXIN RECEPTOR INTERACTIONS
|
BRADLEY, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$319,442
|
Infectious Diseases
|
NIAID
|
5U01AI061246-04
|
|
DNA Minor Groove-binding Drugs and Food-borne Pathogens
|
PERRELLA, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$408,264
|
Infectious Diseases
|
NCI
|
5R01CA124621-02
|
|
Role of Arsenic Trioxide in Primary Effusion Lymphoma
|
CHAUDHARY, PREET
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$278,353
|
Infectious Diseases
|
NIAID
|
5R01AI048496-07
|
|
Improved Brucella Vaccine Strains
|
FICHT, THOMAS
|
TEXAS AGRILIFE RESEARCH
|
TX
|
$346,491
|
Infectious Diseases
|
NIGMS
|
5R01GM055769-09
|
|
NMR Studies of Bacterial Regulatory Proteins
|
CAVANAGH, JOHN
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$213,396
|
Infectious Diseases
|
NIEHS
|
5K99ES015426-02
|
|
Mercury exposure and the innate immune response in autoimmune heart disease
|
NYLAND, JENNIFER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$88,415
|
Infectious Diseases
|
NIAID
|
1R13AI075650-01
|
|
Keystone Symposium on Lymphocyte Activation and Signaling
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$10,000
|
Infectious Diseases
|
NHLBI
|
5R01HL061038-09
|
|
Virus-Induced Mechanics of Altered Airway Responsiveness
|
GRUNSTEIN, MICHAEL
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$362,680
|
Infectious Diseases
|
NIAID
|
5R01AI062888-04
|
|
DC-mediated Homeostatic Prolif. of CD4 T Cells by TSLP
|
LIU, YONG-JUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$280,910
|
Infectious Diseases
|
NIAID
|
5R01AI034432-14
|
|
Polyamine and glutathione metabolism in trypanosomes.
|
PHILLIPS, MARGARET
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$326,489
|
Infectious Diseases
|
NIAID
|
5R01AI011744-33
|
|
Coordination Chemistry of Microbial Iron Transport
|
RAYMOND, KENNETH
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$324,363
|
Infectious Diseases
|
NIAID
|
5R01AI059523-04
|
|
Orgin of multidrug resistant uropathogenic E. coli
|
RILEY, LEE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$282,770
|
Infectious Diseases
|
NHLBI
|
5R01HL073870-04
|
|
Limiting Inflammation in the CF Lung
|
DAVIS, PAMELA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$508,294
|
Infectious Diseases
|
NHLBI
|
5R01HL077095-04
|
|
Immune response to Pneumocystis in simian model of AIDS
|
NORRIS, KAREN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$580,262
|
Infectious Diseases
|
NIAID
|
5R01AI034937-13
|
|
Genetics of Iron Acquisition by Legionella pneumophila
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$308,537
|
Infectious Diseases
|
NIAID
|
5R01AI043987-10
|
|
Type II Secretion and Legionella pneumophila Infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$239,471
|
Infectious Diseases
|
NIAID
|
5R01AI062832-04
|
|
Immunity to Intracellular Pathogens
|
UNANUE, EMIL
|
WASHINGTON UNIVERSITY
|
MO
|
$355,788
|
Infectious Diseases
|
NIAID
|
5R37AI047367-09
|
|
HCV-specific T cell response
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$541,702
|
Infectious Diseases
|
NIGMS
|
5R01GM038130-15
|
|
Investigations of the Bioinorganic Chemistry of Iron: New Siderophores
|
BUTLER, ALISON
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$247,651
|
Infectious Diseases
|
NIGMS
|
5R01GM053008-14
|
|
Modulation of Hepatocellular Function in Sepsis
|
WANG, PING
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$311,458
|
Infectious Diseases
|
NIEHS
|
5F32ES015414-02
|
|
Application of ABC transporters toward enhanced arsenic detoxification
|
PISCHKE, MELISSA
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$51,278
|
Infectious Diseases
|
NIAID
|
7R01AI058107-04
|
|
PRIMATE MODEL AND PATHOGENESIS OF ANTHRAX SEPSIS
|
KUROSAWA, SHINICHIRO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$487,215
|
Infectious Diseases
|
NINDS
|
1R43NS060199-01
|
|
Development of a high-throughput screen for inhibitors of water permeability thro
|
PELLETIER, MARC
|
AEROMICS, LLC
|
OH
|
$300,000
|
Infectious Diseases
|
NIGMS
|
1R13GM081929-01
|
|
Molecular Basis for Biological Membrane Organization
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$5,000
|
Infectious Diseases
|
NIAID
|
5R01AI055352-05
|
|
Novel Antimicrobial Agents Against M. tuberculosis
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$454,104
|
Infectious Diseases
|
NIA
|
5F32AG027641-03
|
|
Enhancing Aged CD4+ T Cell Immunity to Influenza
|
JONES, STEPHEN
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$24,853
|
Infectious Diseases
|
NIAID
|
5R01AI060753-03
|
|
Nasal carriage of S. aureus: host-pathogen interactions
|
COLE, ALEXANDER
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$306,483
|
Infectious Diseases
|
NIAID
|
5R01AI054476-05
|
|
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
|
RIKIHISA, YASUKO
|
OHIO STATE UNIVERSITY
|
OH
|
$347,649
|
Infectious Diseases
|
NIDCD
|
5R01DC008600-02
|
|
Molecular Biology of the Odorant Receptors
|
VOSSHALL, LESLIE
|
ROCKEFELLER UNIVERSITY
|
NY
|
$319,011
|
Infectious Diseases
|
NIDDK
|
5F32DK067781-03
|
|
Cis- and Trans-acting Factors in HCV Gene Expression
|
BRADRICK, SHELTON
|
DUKE UNIVERSITY
|
NC
|
$52,048
|
Infectious Diseases
|
NIAID
|
5R01AI033108-15
|
|
Endocrinology of Mosquito Reproduction
|
BROWN, MARK
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$270,756
|
Infectious Diseases
|
NIDDK
|
5R01DK038201-20
|
|
Regulation of sinusoidal perfusion in shock
|
CLEMENS, MARK
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$215,604
|
Infectious Diseases
|
NIDA
|
1R01DA024864-01
|
|
Drug Use and Other Risk Factors for HIV Infection in Female Sex Workers in China
|
WANG, NING
|
NATIONAL CENTER/AIDS/STD CONTROL/PREVENT
|
CHINA
|
$93,223
|
Infectious Diseases
|
NIAID
|
5R01AI068715-02
|
|
Characterization of a novel AB5 cytotoxin
|
PATON, ADRIENNE
|
UNIVERSITY OF ADELAIDE
|
AUSTRA
|
$264,871
|
Infectious Diseases
|
NHLBI
|
5R01HL076278-04
|
|
Macrophage Inflammasome Regulation
|
WEWERS, MARK
|
OHIO STATE UNIVERSITY
|
OH
|
$354,382
|
Infectious Diseases
|
NIAID
|
5R01AI047206-06
|
|
The CD8 T cell response to murine cytomegalovirus
|
HILL, ANN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$377,685
|
Infectious Diseases
|
NIAID
|
5R01AI069987-02
|
|
Novel HIV-1 vaccine candidates using newly transmitted clade C Envs as immunogens
|
BLACKWELL, JERRY
|
EMORY UNIVERSITY
|
GA
|
$373,025
|
Infectious Diseases
|
NIAID
|
5R01AI064842-04
|
|
A new target for malaria drug development
|
LEVIN, LONNY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$312,535
|
Infectious Diseases
|
NIMH
|
5R01MH079752-02
|
|
Role of evolving white matter damage in neurocognitive effects of HIV and HCV
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$347,625
|
Infectious Diseases
|
NINR
|
1R43NR010440-01
|
|
Biocidal Surfaces for Medical Hardware
|
LAMBA, NINA
|
CCL BIOMEDICAL, INC.
|
MD
|
$100,000
|
Infectious Diseases
|
NIAID
|
5R01AI064003-04
|
|
Retrovirus Restriction by Trima5alpha
|
BIENIASZ, PAUL
|
AARON DIAMOND AIDS RESEARCH CENTER
|
NY
|
$418,574
|
Infectious Diseases
|
NIAID
|
5R01AI023302-22
|
|
Monoclonal Antibodies for the Study of P. carinii
|
GIGLIOTTI, FRANCIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$362,764
|
Infectious Diseases
|
NHLBI
|
5K08HL076538-02
|
|
Inflammatory and Chemotactic Cytokines in Bronchopulmonary Dysplasia
|
LONDHE, VEDANG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$121,770
|
Infectious Diseases
|
NIAID
|
5R01AI072732-03
|
|
Inhibition of Anthrax Lethal Factor by alpha-defensins
|
LU, WUYUAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$367,875
|
Infectious Diseases
|
NIAID
|
5R01AI063516-03
|
|
Brucella Iron Metabolism in Host Macrophages
|
ROOP, ROY
|
EAST CAROLINA UNIVERSITY
|
NC
|
$305,412
|
Infectious Diseases
|
NIAID
|
5R01AI044005-10
|
|
Antigenic variation in rickettsial transmission
|
PALMER, GUY
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$273,096
|
Infectious Diseases
|
NIAID
|
5R01AI065529-02
|
|
Regulatory Networks of Helicobacter pylori
|
MERRELL, D
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$374,742
|
Infectious Diseases
|
NIAID
|
5R01AI072661-02
|
|
Structural Analysis of Vibrio cholerae Virulence Gene Regulatory Proteins
|
KULL, F
|
DARTMOUTH COLLEGE
|
NH
|
$392,155
|
Infectious Diseases
|
NIAID
|
5R01AI054423-05
|
|
Genetic requirements of Helicobacter pylori infection
|
SALAMA, NINA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$356,805
|
Infectious Diseases
|
NIAID
|
5R01AI069085-02
|
|
M. tuberculosis lipoprotein-TLR2 interactions
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$378,911
|
Infectious Diseases
|
NIAID
|
5R01AI039973-12
|
|
Biochemical Mechanisms of Drug Resistance in HIV-1 RT
|
SCOTT, WALTER
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$352,300
|
Infectious Diseases
|
NIAID
|
5R01AI035705-15
|
|
Staphylococcal methicillin resistance locus
|
ARCHER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$489,096
|
Infectious Diseases
|
NIAID
|
5R01AI064705-03
|
|
Viral recognition by plasmacytoid dendritic cell
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$389,355
|
Infectious Diseases
|
NCI
|
5R01CA082036-09
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$443,347
|
Infectious Diseases
|
NIAID
|
5R01AI036525-11
|
|
Immune Mechanisms of Protection in S Typhi Vaccines
|
SZTEIN, MARCELO
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$439,396
|
Infectious Diseases
|
NIMH
|
5R34MH078719-02
|
|
Reducing Teen Risky Behavior: A Clinic-Based Approach
|
GUILAMO-RAMOS, VINCENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$289,800
|
Infectious Diseases
|
NIAID
|
5R01AI041014-11
|
|
Developmental Biology of Toxoplasma
|
BOOTHROYD, JOHN
|
STANFORD UNIVERSITY
|
CA
|
$344,307
|
Infectious Diseases
|
NHLBI
|
5R01HL083194-03
|
|
Mechanisms of CMV latency in accelerated vascular disease
|
STREBLOW, DANIEL
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$299,068
|
Infectious Diseases
|
NIAID
|
1R13AI075719-01
|
|
International Congress of Virology, Istanbul, ASV Travel Request
|
SAWICKI, DOROTHEA
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$30,000
|
Infectious Diseases
|
NIAID
|
2P01AI053725-06
|
0006
|
Glycolipid Specific T Cell Responses
|
BENDELAC, ALBERT
|
UNIVERSITY OF CHICAGO
|
IL
|
$274,926
|
Infectious Diseases
|
NIAID
|
5R01AI048849-07
|
|
MHC Class I Antigen Presentation in Viral Infections
|
SIGAL, LUIS
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$419,378
|
Infectious Diseases
|
NIAID
|
5R44AI056944-05
|
|
Antibody-Biocide Fusions to Control Cryptosporidium
|
IMBODEN, MICHAEL
|
IOGENETICS, LLC
|
WI
|
$1,151,226
|
Infectious Diseases
|
NHLBI
|
5K08HL083095-02
|
|
Role of Calcium-Activated Chloride Channels in Airway Disease Phenotypes
|
PATEL, ANAND
|
WASHINGTON UNIVERSITY
|
MO
|
$119,718
|
Infectious Diseases
|
NIAID
|
5R01AI046433-09
|
|
Protease and ROP Genes in S Pyogenes Virulence
|
CAPARON, MICHAEL
|
WASHINGTON UNIVERSITY
|
MO
|
$320,211
|
Infectious Diseases
|
NIGMS
|
5R01GM049530-24
|
|
Genetic Functions of an Enterococcal R Factor
|
DUNNY, GARY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$294,949
|
Infectious Diseases
|
NIAID
|
5R01AI072479-02
|
|
Analysis of gene regulation of Vibrio cholerae infection
|
ZHU, JUN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$379,502
|
Infectious Diseases
|
NIAID
|
5R01AI072613-02
|
|
Identification and characterization of cellular factors involved in HCV entry
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$414,473
|
Infectious Diseases
|
NIAID
|
5R01AI069345-02
|
|
Autophagy in Tuberculosis
|
DERETIC, VOJO
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$365,423
|
Infectious Diseases
|
NIAID
|
5R01AI070863-02
|
|
SCREEN DEVELOPMENT FOR ANTIMICROBIAL PRODRUGS
|
LEWIS, KIM
|
NORTHEASTERN UNIVERSITY
|
MA
|
$385,043
|
Infectious Diseases
|
NIAID
|
5R01AI039454-12
|
|
Toxoplasma encephalitis in AIDS: Bradyzoite Regulation
|
WEISS, LOUIS
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
Infectious Diseases
|
NIAID
|
5R01AI067417-03
|
|
Molecular Modulation of HBV Capsid Assembly
|
ZLOTNICK, ADAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$345,885
|
Infectious Diseases
|
NIGMS
|
5R01GM057045-11
|
|
Forespore Engulfment During B subtilis Sporulation
|
POGLIANO, KIT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$320,412
|
Infectious Diseases
|
NIGMS
|
5R01GM052190-14
|
|
Organic Nanotubes Design and Biological Applications
|
GHADIRI, M.
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$414,010
|
Infectious Diseases
|
NIAID
|
5R01AI072508-02
|
|
Novel whole-animal screens for anti-microbials
|
AUSUBEL, FREDERICK
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$415,454
|
Infectious Diseases
|
NIAID
|
5R01AI063496-03
|
|
Immune Regulation by Gadd45b and Gadd45g
|
LU, BINFENG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$301,640
|
Infectious Diseases
|
NIAID
|
5R01AI025825-21
|
|
Molecular Analysis of FIV
|
ELDER, JOHN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$371,799
|
Infectious Diseases
|
NHLBI
|
5R01HL076586-04
|
|
Structure-Function Relationships in Lung Surfactants
|
LONG, JOANNA
|
UNIVERSITY OF FLORIDA
|
FL
|
$272,254
|
Infectious Diseases
|
NIAID
|
5R01AI044238-10
|
|
Species-specific regulated transposition in mosquitoes
|
JAMES, ANTHONY
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$351,413
|
Infectious Diseases
|
NIAID
|
5R01AI050080-07
|
|
Mechanisms of Reovirus-Induced Apoptosis
|
DERMODY, TERENCE
|
VANDERBILT UNIVERSITY
|
TN
|
$338,813
|
Infectious Diseases
|
NIAID
|
5R01AI066058-02
|
|
Legionella pneumophila developmental cycle & virulence
|
HOFFMAN, PAUL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$370,162
|
Infectious Diseases
|
NIAID
|
5R01AI026522-30
|
|
Structure and Replication of Hepatitis Delta Virus
|
TAYLOR, JOHN
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$632,726
|
Infectious Diseases
|
NIAID
|
5R01AI042015-10
|
|
Regulation of the (poly) sialic virulence factor
|
VIMR, ERIC
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$177,895
|
Infectious Diseases
|
NIAID
|
5R01AI068645-03
|
|
Cloning a major gene for mouse adenovirus susceptibility
|
SPINDLER, KATHERINE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$351,795
|
Infectious Diseases
|
NIAID
|
5R01AI059176-05
|
|
Infectivity and Transmission of Toxoplasmosis
|
SIBLEY, L
|
WASHINGTON UNIVERSITY
|
MO
|
$355,788
|
Infectious Diseases
|
NIGMS
|
5R01GM063270-08
|
|
Mathematical models of H. pylori gastric colonization
|
BLASER, MARTIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$256,013
|
Infectious Diseases
|
NIAID
|
5R01AI057637-04
|
|
Clostridium difficile Toxin Gene Regulation
|
SONENSHEIN, ABRAHAM
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$265,401
|
Infectious Diseases
|
NHLBI
|
5R01HL078860-03
|
|
Role of Epithelium in Immunity, Inflammation and Disease
|
SCHLEIMER, ROBERT
|
NORTHWESTERN UNIVERSITY
|
IL
|
$366,553
|
Infectious Diseases
|
NIAID
|
5R01AI039657-12
|
|
Structure-function analysis of H. pylori VacA
|
COVER, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$346,156
|
Infectious Diseases
|
NIAID
|
5R01AI045764-08
|
|
IMMUNE POTENTIAL OF ANIMAL LACKING CLASS IA MOLECULES
|
FORMAN, JAMES
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$333,563
|
Infectious Diseases
|
NIAID
|
5R01AI032042-15
|
|
Methods for Evaluating Vaccine Efficacy
|
HALLORAN, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$438,180
|
Infectious Diseases
|
NIAID
|
5R01AI054578-04
|
|
Pathogenesis of Oxidative Stress in Chagasic Myocarditis
|
GARG, NISHA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$269,050
|
Infectious Diseases
|
NIDDK
|
5R01DK073902-03
|
|
Mechanism that regulate Helicobacter pylori-induced beta-caterin activation
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY
|
TN
|
$290,565
|
Infectious Diseases
|
NIAID
|
5R01AI046985-08
|
|
Serine Proteinases in Apicomplexan Parasites
|
KIM, KAMI
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
Infectious Diseases
|
NHLBI
|
5R01HL077417-03
|
|
Regulation of Pulmonary Host Defense by Leptin
|
MANCUSO, PETER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$353,359
|
Infectious Diseases
|
NIAID
|
5R01AI047033-07
|
|
The Transmission and Fitness of Drug Resistant HIV-1
|
MARKOWITZ, MARTIN
|
AARON DIAMOND AIDS RESEARCH CENTER
|
NY
|
$596,433
|
Infectious Diseases
|
NIAID
|
5R01AI037901-11
|
|
Characterization of Mycobacterial Sigma Factors
|
HUSSON, ROBERT
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$416,676
|
Infectious Diseases
|
NIAID
|
5R01AI029646-19
|
|
MOLECULAR GENETICS OF LEISHMANIA
|
BEVERLEY, STEPHEN
|
WASHINGTON UNIVERSITY
|
MO
|
$630,243
|
Infectious Diseases
|
NIDCR
|
5R01DE014699-05
|
|
Intergeneric Signaling Molecules of S. cristatus
|
XIE, HUA
|
MEHARRY MEDICAL COLLEGE
|
TN
|
$165,436
|
Infectious Diseases
|
NIDCR
|
5R01DE015348-04
|
|
Genetic Systems for Fusobacterium nucleatum
|
KINDER HAAKE, SUSAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$253,545
|
|